Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
申请人:——
公开号:US20030013733A1
公开(公告)日:2003-01-16
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
OCTAHYDRO-INDOLIZINE AND QUINOLIZINE AND HEXAHYDRO-PYRROLIZINES
申请人:Apodaca Richard
公开号:US20090263322A1
公开(公告)日:2009-10-22
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
Octahydroindolizine compounds useful as analgesics
申请人:McNeilab, Inc.
公开号:EP0187711A2
公开(公告)日:1986-07-16
Octahydroindolizidines of the formula (I):
where A is a 3-7 carbon or hetero-containing ring, R' is a substituent and x is 0-3. Also, pharmaceutical composition for treating pain and methods for synthesis and use as well as novel intermediates in the synthesis.
式(I)的八氢吲嗪类化合物:
其中 A 是 3-7 个含碳或含杂环,R'是取代基,x 是 0-3。此外,还有治疗疼痛的药物组合物、合成和使用方法以及合成过程中的新型中间体。
OCTAHYDRO-INDOLIZINES AND QUINOLIZINES AND HEXAHYDRO-PYRROLIZINES